QUE Oncology

QUE Oncology is a clinical-stage company developing non-hormonal therapies for moderate to severe vasomotor symptoms in postmenopausal women and cancer patients undergoing hormone therapy. Their lead product, Q-122, has completed a Phase 2 trial for treating hot flashes in breast cancer patients across Australia, New Zealand, and the US. The company was founded in 2013 through a joint venture between Emory University and the University of Queensland's research commercialization company, UniQuest.

• Healthtech

Visit website ↗